Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NeurogesX Inc (OTC Pink - No Information:NGSX)

0.0042
Delayed Data
As of 9:30am ET
 -0.0001 / -2.33%
Today’s Change
0.00
Today|||52-Week Range
0.02
+23.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$143.3K

Company Description

NeurogesX, Inc. is a biopharmaceutical company, which is focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs. Its product Qutenza, a synthetic capsaicin-based dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. The company was formerly known as Advanced Analgesics, Inc. and changed its name to NeurogesX, Inc. in September 2000. NeurogesX was founded by Wendye R. Robbins on May 28, 1998 and is headquartered in San Mateo, CA.

Contact Information

NeurogesX, Inc.
999 Baker Street
San Mateo California 94404
P:(650) 358-3300
Investor Relations:

Employees

Shareholders

Other institutional6.17%
Individual stakeholders43.77%
Mutual fund holders0.30%

Top Executives

Stephen F. GhiglieriChief Operating Officer, CFO, Secretary & EVP
Stephen J. PeroutkaChief Medical Officer & Executive Vice President
Russell T. KawahataVice President-Pharmaceutical Science
Linda L. SchockDirector-Commercial Operations